Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02132663 · ClinicalTrials.gov registry record · NA
The Effects on Growth and Tolerance of a Routine Infant Formula Fed to Term Infants
A NA study, sponsored by Mead Johnson Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 315
- Enrollment target
NCT02132663 is a NA study that has completed, run by Mead Johnson Nutrition. The registered enrollment target is 315 participants.
The verdict
NCT02132663, a NA study, has completed, sponsored by Mead Johnson Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 315 participants
- Enrollment target
Study Summary
This clinical trial will evaluate an investigational infant formula with an alternate source of DHA to determine if it provides normal growth and if it is well tolerated by term infants as compared to a marketed routine infant formula.
Interventions
- OTHER Control: Marketed routine infant formula
- OTHER An investigational infant formula containing an alternate source of DHA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02132663
The ClinicalTrials.gov registry entry for NCT02132663 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 315 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mead Johnson Nutrition, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control: Marketed routine infant formula is the first listed.
NCT02132663 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02132663 about?
NCT02132663 is a clinical study titled "The Effects on Growth and Tolerance of a Routine Infant Formula Fed to Term Infants". This clinical trial will evaluate an investigational infant formula with an alternate source of DHA to determine if it provides normal growth and if it is well tolerated by term infants as compared to a marketed routine infant formula.
What is the current status of trial NCT02132663?
This trial is currently completed. It is a NA study. The enrollment target is 315 participants. The study started on 2014-05. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02132663?
The interventions under investigation include: Control: Marketed routine infant formula (OTHER), An investigational infant formula containing an alternate source of DHA (OTHER).
Who is sponsoring clinical trial NCT02132663?
This trial is sponsored by Mead Johnson Nutrition, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.